DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Estrace (Estradiol Vaginal) - Adverse Event Reports - Death - Breast Cancer Metastatic

 



Index of reports > Cases resulting in death (7) > Cases with Breast Cancer Metastatic (2)

Below is the selection of adverse event reports related to Estrace (Estradiol Vaginal) that includes cases resulting in death where reactions include breast cancer metastatic.

Adverse event in female receiving Estrace (Estradiol Vaginal)

Reported by a consumer/non-health professional from United States on 2007-03-09

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: death

Suspect drug(s):
Premarin
    Indication: Oestrogen Replacement Therapy

Estrace
    Indication: Hormone Replacement Therapy



Adverse event in female receiving Estrace (Estradiol Vaginal)

Reported by a lawyer from United States on 2007-03-07

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic, Breast Cancer Female

Adverse event resulted in: death

Suspect drug(s):
Estradiol
    Dosage: oral
    Administration route: Oral
    Start date: 1985-01-01
    End date: 1999-01-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1985-01-01
    End date: 1995-01-01

Estrace
    Dosage: oral
    Administration route: Oral
    Start date: 1985-01-01
    End date: 1999-01-01

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009